These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31470021)

  • 21. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats.
    Bruijnzeel AW; Markou A
    Brain Res; 2005 Oct; 1058(1-2):91-100. PubMed ID: 16126181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
    Harrison AA; Gasparini F; Markou A
    Psychopharmacology (Berl); 2002 Feb; 160(1):56-66. PubMed ID: 11862374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
    Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
    Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pimavanserin and lorcaserin on alcohol self-administration and reinstatement in male and female rats.
    Fletcher PJ; Li Z; Ji X; Higgins GA; Funk D; Lê AD
    Neuropharmacology; 2022 Sep; 215():109150. PubMed ID: 35644487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.
    Levin ED; Wells C; Slade S; Rezvani AH
    Pharmacol Biochem Behav; 2018 Mar; 166():42-47. PubMed ID: 29407477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D1-like receptor activation decreases nicotine intake in rats with short or long access to nicotine.
    Chellian R; Behnood-Rod A; Wilson R; Lin K; King GW; Bruijnzeel AW
    Addict Biol; 2023 Aug; 28(8):e13312. PubMed ID: 37500487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior.
    See RE; Kruzich PJ; Grimm JW
    Psychopharmacology (Berl); 2001 Mar; 154(3):301-10. PubMed ID: 11351937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
    Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
    Ramos M; Goñi-Allo B; Aguirre N
    Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential region-specific regulation of α4β2* nAChRs by self-administered and non-contingent nicotine in C57BL/6J mice.
    Metaxas A; Bailey A; Barbano MF; Galeote L; Maldonado R; Kitchen I
    Addict Biol; 2010 Oct; 15(4):464-79. PubMed ID: 20731631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
    Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM
    Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tranylcypromine enhancement of nicotine self-administration.
    Villégier AS; Lotfipour S; McQuown SC; Belluzzi JD; Leslie FM
    Neuropharmacology; 2007 May; 52(6):1415-25. PubMed ID: 17412372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor systems participating in nicotine-specific effects.
    Sziráki I; Sershen H; Benuck M; Hashim A; Lajtha A
    Neurochem Int; 1998 Nov; 33(5):445-57. PubMed ID: 9874095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
    Bishop C; Daut GS; Walker PD
    Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The serotonin 2C receptor agonist lorcaserin, alone and in combination with the opioid receptor antagonist naltrexone, attenuates binge-like ethanol drinking.
    Tabbara RI; Li Z; Fletcher PJ; Lê AD
    Addict Biol; 2021 Sep; 26(5):e13040. PubMed ID: 33928736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
    O'Connor EC; Parker D; Rollema H; Mead AN
    Psychopharmacology (Berl); 2010 Feb; 208(3):365-76. PubMed ID: 19967529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.
    Guy EG; Fletcher PJ
    Pharmacol Biochem Behav; 2014 Oct; 125():40-47. PubMed ID: 25158104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.